Hence, the intrathecal delivery of NGF enhances the analgesic effect of fentanyl on diabetes-related hyperalgesia, which could explain why anti-NGF mAbs exhibit limited antinociceptive effects (Shaqura et al. 2013). Here, NGF is linked to diabetes mellitus.